A Randomized, Pilot Study to Assess the Efficacy and Safety of Curcumin in Patients with Active Rheumatoid Arthritis
Top Cited Papers
- 9 March 2012
- journal article
- research article
- Published by Wiley in Phytotherapy Research
- Vol. 26 (11), 1719-1725
- https://doi.org/10.1002/ptr.4639
Abstract
Curcumin is known to possess potent antiinflammatory and antiarthritic properties. This pilot clinical study evaluated the safety and effectiveness of curcumin alone, and in combination with diclofenac sodium in patients with active rheumatoid arthritis (RA). Forty‐five patients diagnosed with RA were randomized into three groups with patients receiving curcumin (500 mg) and diclofenac sodium (50 mg) alone or their combination. The primary endpoints were reduction in Disease Activity Score (DAS) 28. The secondary endpoints included American College of Rheumatology (ACR) criteria for reduction in tenderness and swelling of joint scores. Patients in all three treatment groups showed statistically significant changes in their DAS scores. Interestingly, the curcumin group showed the highest percentage of improvement in overall DAS and ACR scores (ACR 20, 50 and 70) and these scores were significantly better than the patients in the diclofenac sodium group. More importantly, curcumin treatment was found to be safe and did not relate with any adverse events. Our study provides the first evidence for the safety and superiority of curcumin treatment in patients with active RA, and highlights the need for future large‐scale trials to validate these findings in patients with RA and other arthritic conditions. Copyright © 2012 John Wiley & Sons, Ltd.Keywords
This publication has 31 references indexed in Scilit:
- The value of early intervention in RA—a window of opportunityClinical Rheumatology, 2011
- Curcumin, the Golden Spice From Indian Saffron, Is a Chemosensitizer and Radiosensitizer for Tumors and Chemoprotector and Radioprotector for Normal OrgansNutrition and Cancer, 2010
- Diclofenac Sodium Gel in Patients with Primary Hand Osteoarthritis: A Randomized, Double-blind, Placebo-controlled TrialThe Journal of Rheumatology, 2009
- Efficacy, safety and patient-reported outcomes of combination etanercept and sulfasalazine versus etanercept alone in patients with rheumatoid arthritis: a double-blind randomised 2-year studyAnnals Of The Rheumatic Diseases, 2008
- Multi‐targeted therapy by curcumin: how spicy is it?Molecular Nutrition & Food Research, 2008
- A pilot cross-over study to evaluate human oral bioavailability of BCM-95®CG (BiocurcumaxTM), a novel bioenhanced preparation of curcuminIndian Journal of Pharmaceutical Sciences, 2008
- Curcumin Prevents Tumor-induced T Cell Apoptosis through Stat-5a-mediated Bcl-2 InductionOnline Journal of Public Health Informatics, 2007
- CURCUMIN: THE INDIAN SOLID GOLDAdvances in experimental medicine and biology, 2006
- Molecular targets of dietary agents for prevention and therapy of cancerBiochemical Pharmacology, 2006
- The PREMIER study: A multicenter, randomized, double‐blind clinical trial of combination therapy with adalimumab plus methotrexate versus methotrexate alone or adalimumab alone in patients with early, aggressive rheumatoid arthritis who had not had previous methotrexate treatmentArthritis & Rheumatism, 2005